Immunohistochemistry (IHC) Market Dynamics: Size, Share & Future Trends
The Immunohistochemistry Market is projected to grow at a 7.2% CAGR from 2024 to 2031, reaching $4.08 billion by the end of the period.
Oncology Information Systems Market to be Worth $4.45 Billion by 2030
Meticulous Research®—a leading global market research company, published a research report titled, ‘Oncology Information Systems Market by Offering (Software {Patient Information, Treatment Planning} Services) Application (Medical, Surgical, Radiology Oncology) End User (Hospital, Diagnostic Imaging Center, Cancer Care Center) - Global Forecast to 2030.’Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5591?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=10-01-2024
According to this latest publication from Meticulous Research®, the oncology information systems market is projected to reach $4.45 billion by 2030, at a CAGR of 7.4% from 2023 to 2030. The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, rising need to reduce oncology care costs, increasing adoption of electronic health records (EHR), and increased demand for streamlined patient information and data management. In addition, the integration of precision medicine for cancer treatment and its potential in emerging countries are expected to provide significant growth opportunities for this market.
However, the high cost of oncology information systems and data security & privacy concerns are expected to restrain the growth of this market to a certain extent. In addition, factors such as barriers to adoption and implementation and additional requirement for training and education for using oncology information systems pose major challenges to the market’s growth.
Key Players
The key players operating in the oncology information systems market are Accuray Incorporated (U.S.), Brainlab AG (Germany), DOSIsoft SA (France), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories (Sweden), Siemens Healthcare GmbH (Germany), McKesson Corporation (U.S.), Altai, Inc (Turkey), and ViewRay Inc. (U.S.).
Browse in depth @ https://www.meticulousresearch.com/product/oncology-information-systems-market-5591?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=10-01-2024
Oncology Information Systems Market: Future Outlook
The oncology information systems market is segmented by offering, application, end user, and geography. The study also evaluates industry competitors and analyzes the country and regional–level markets.
Among the offerings studied in this report, in 2023, the software segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to factors such as higher adoption of software solutions by the hospitals, the rising need for managing cancer-related data, and its benefits such as optimizing treatment planning & delivery.
Among all the applications, in 2023, the medical oncology segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to the large patient population receiving medical oncology care and the benefits of oncology information systems in managing departmental, administrative, and clinical activities in medical oncology.
Speck to our analyst @ https://www.meticulousresearch.com/speak-to-analyst/cp_id=5591?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=10-01-2024
In 2023, the hospitals segment is expected to account for the largest share of the oncology information systems market, by end user. The large market share of this segment is attributed to the increased adoption of digital solutions, including oncology information systems in hospitals, the increased awareness about its benefits among healthcare professionals, and the rising patient population.
Geographic Review
This research report analyzes the market across major regions and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, the U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, India, and the Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the oncology information systems market, followed by Europe and Asia-Pacific. North America’s major market share is attributed to the advanced healthcare infrastructure in the region, higher acceptance of advanced technologies, and the high number of cancer patients.
Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5591?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=10-01-2024
Please login to comment on this Post